Galactocerebrosidase deficiency, commonly known as Krabbe disease, is a genetic disease that breaks up the myelin, a protective coating of the brain and each part of the nervous system.
The signs and symptoms of galactocerebrosidase deficiency normally appear in babies before they reach six months, and the illness typically causes death by the age of two. When it affects adults and children, the development of the disorder can differ substantially.
There is no cure for galactocerebrosidase deficiency. Thus, supportive care is the main treatment. On the other hand, stem cell transplants have shown some potential in newborns who are cured before the beginning of symptoms, as well as in some adults and children.